Sensory testing might not be perfect - but it is the best biomarker for pain phenotypes we have right now.

Abstract excerpt

Currently available treatments for neuropathic pain fail in roughly half of the patients - and it is impossible to predict which treatments will help patients. Stratification of neuropathic pain patients is needed, and sensory profiling has so far been the most promising approach: it has been shown to be responsive to treatment, linked to potential mechanisms, and, most importantly, predictive of treatment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Neuralgia
• Share to Pain Measurement